Clinical Trial Update: Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

View source ↗

Summary

This completed clinical trial evaluates the effect of pre-transplant tyrosine kinase inhibitors on outcomes, including survival, in hepatocellular carcinoma pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tyrosine kinase inhibitors

Snippet

Sponsor: Hu Liangshuo | Conditions: Liver Transplantation, Hepatocellular Carcinoma (HCC) | Status: COMPLETED